Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia

American Journal of Kidney Diseases

Volumn 57, Issue 1, 2011, Pages 181-182

  Hu, Susie ^a   Shearer, Gregory C ^b   Steffes, Michael W ^c   Harris, William S ^b   Bostom, Andrew G ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; CREATININE; NICOTINIC ACID; PHOSPHORUS;

ALBUMIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED DRUG RELEASE; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; HUMAN; KIDNEY FUNCTION; LETTER; PHOSPHATE BLOOD LEVEL;

CALCIUM; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DYSLIPIDEMIAS; GLOMERULAR FILTRATION RATE; HUMANS; HYPOLIPIDEMIC AGENTS; METABOLIC SYNDROME X; NIACIN; PHOSPHORUS; SERUM ALBUMIN;

EID: 78650521671     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.06.029     Document Type: Letter

References (10)

1. A.G. Bostom Binder blindersniacin of omission? Am J Kidney Dis 55 4 2010 628 630
2. M. Chonchol, R. Dale, R.W. Schrier, and R. Estacio Serum phosphorus and cardiovascular mortality in type 2 diabetes Am J Med 122 4 2009 380 386
3. D. Maccubbin, D. Tipping, O. Kuznetsova, W.A. Hanlon, and A.G. Bostom Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial Clin J Am Soc Nephrol 5 4 2010 582 589
4. Shearer GC, Pottala JV, Harris WS. Effects of niacin and omega-3 fatty acids on the metabolic syndrome: a randomized, controlled trial [abstract P150]. Poster presentation at the Arteriosclerosis, Thrombosis, and Vascular Biology 2010 Scientific Sessions, April 9, 2010, San Francisco, CA. NCT00286234. http://cinicaltrials.gov/ct2/show/NCT00286234. Accessed September 14, 2010.
5. A.S. Levey, L.A. Stevens, and C.H. Schmid CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
6. Y.W. Chiu, I. Teitelbaum, M. Misra, E.M. de Leon, T. Adzize, and R. Mehrotra Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients Clin J Am Soc Nephrol 4 6 2009 1089 1096
7. R.B. Oliveira, A.L. Cancela, and F.G. Graciolli Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKDMBD therapy? Clin J Am Soc Nephrol 5 2 2010 286 291
8. G.A. Block, M.S. Persky, and M. Ketteler A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology Hemodial Int 13 3 2009 360 362
9. T. Isakova, O.M. Gutierrez, and M. Wolf A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease Kidney Int 76 7 2009 705 711
10. J.K. Duggal, M. Singh, and N. Attri Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease J Cardiovasc Pharmacol Ther 15 2 2010 158 166